News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Flynn Daniel Lee
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/19/2023 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 2,403 shares
@ $21.2413, valued at
$51k
|
|
| 06/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 1,366 shares
@ $9.05, valued at
$12.4k
|
|
| 01/20/2022 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Granted 20,500 shares
@ $0
Granted 82,000 options to buy
@ $8.27, valued at
$678.1k
|
|
| 12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/22/2020 |
4/A
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 10,106 options to buy
@ $3.95, valued at
$39.9k
|
|
| 01/21/2020 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 10,106 options to buy
@ $3.95, valued at
$39.9k
Exercised 56,800 options to buy
@ $6.13, valued at
$348.2k
|
|
| 12/13/2019 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 31,029 shares
@ $60, valued at
$1.9M
|
|
| 12/11/2019 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 30,175 shares
@ $55, valued at
$1.7M
Sold 28,822 shares
@ $55, valued at
$1.6M
Sold 93,930 shares
@ $55, valued at
$5.2M
Exercised 30,175 options to buy
@ $1.89, valued at
$57k
Exercised 28,822 options to buy
@ $1.89, valued at
$54.5k
Exercised 93,930 options to buy
@ $1.89, valued at
$177.5k
|
|
| 11/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2019 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Gifted 55,270 shares
@ $0 |
|
| 02/25/2019 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Exercised 24,500 options to buy
@ $3.95, valued at
$96.8k
|
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/18/2019 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Gifted 91,779 shares
@ $0
Sold 152,629 shares
@ $26, valued at
$4M
Exercised 152,629 options to buy
@ $1.89, valued at
$288.5k
|
|
| 01/15/2019 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Sold 300 shares
@ $26, valued at
$7.8k
Exercised 300 options to buy
@ $1.89, valued at
$567 |
|
| 09/20/2018 |
4
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 4 on Deciphera Pharmaceuticals, Inc.|
Txns:
| Converted 147,049 shares
@ $0
Converted 22,070 preferred shares
@ $0
Converted 1,494 preferred shares
@ $0
Converted 1,392 preferred shares
@ $0
Converted 1,071 preferred shares
@ $0
Exercised 110,727 options to buy
@ $1.89, valued at
$209.3k
Exercised 625,607 options to buy
@ $1.89, valued at
$1.2M
Exercised 24,607 options to buy
@ $1.89, valued at
$46.5k
Exercised 139,029 options to buy
@ $1.89, valued at
$262.8k
Exercised 7,000 options to buy
@ $3.95, valued at
$27.7k
Exercised 39,550 options to buy
@ $3.95, valued at
$156.2k
|
|
| 09/20/2018 |
3
| Flynn Daniel Lee (Chief Scientific Officer) has filed a Form 3 on Deciphera Pharmaceuticals, Inc. |
|
|